Eliaz Therapeutics, Inc.

Santa Rosa, CA

UEI
Q7MDXXBML3P1
CAGE
7HHW8
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • For Profit Organization
Entity structure
Corporate Entity (Not Tax Exempt)
SAM.gov registration date
Physical address
396 Tesconi Ct, Santa Rosa, CA 95401, USA

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
Depleting circulating galectin-3 with therapeutic apheresis: a noveltreatment for sepsis/AKI - otoliths ("ear… R44GM130227 National Institute of General Medical Sciences (NIH) $3,755,454
Depleting circulating galectin-3 with therapeutic apheresis: a novel treatment for sepsis/AKI. R43GM130227 National Institute of General Medical Sciences (NIH) $224,577

Quick answers

Is Eliaz Therapeutics, Inc. registered in SAM.gov?

Yes. Eliaz Therapeutics, Inc.'s SAM.gov registration is active through January 30, 2027.

What is Eliaz Therapeutics, Inc.'s most recent federal award?

Eliaz Therapeutics, Inc.'s most recent federal grant award is Depleting circulating galectin-3 with therapeutic apheresis: a noveltreatment for sepsis/AKI - otoliths ("ear… (R44GM130227), from National Institute of General Medical Sciences (NIH), on September 1, 2018.

On GovTribe

See Eliaz Therapeutics, Inc.'s full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login